Shareholder alert; pomerantz law firm reminds shareholders with losses on their investment in boston scientific corporation of class action lawsuit and upcoming deadline – bsx

New york, dec. 07, 2020 (globe newswire) -- pomerantz llp announces that a class action lawsuit has been filed against boston scientific corporation (“boston scientific” or the “company”) (nyse: bsx) and certain of its officers.   the class action, filed in united states district court for the eastern district of new york, and docketed under 20-cv-05894, is on behalf of a class consisting of all persons other than defendants who purchased or otherwise, acquired boston scientific securities between april 24, 2019 and november 16, 2020, both dates inclusive (the “class period”), seeking to recover damages caused by defendants' violations of the federal securities laws and to pursue remedies under sections 10(b) and 20(a) of the securities exchange act of 1934 (the “exchange act”) and rule 10b-5 promulgated thereunder, against the company and certain of its top officials.
BSX Ratings Summary
Quant
BSX Quant Ranking
Sector
Industry
Quant Rating
Quant Score